Allspring Global Investments Holdings, LLC Syndax Pharmaceuticals Inc Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 18, 2023
SELL
$19.35 - $22.31 $125,194 - $144,345
-6,470 Reduced 72.12%
2,501 $52,000
Q1 2023

Apr 13, 2023
BUY
$20.66 - $28.98 $91,627 - $128,526
4,435 Added 97.77%
8,971 $189,000
Q4 2022

Jan 23, 2023
SELL
$20.64 - $26.24 $2,538 - $3,227
-123 Reduced 2.64%
4,536 $115 Million
Q3 2022

Oct 26, 2022
BUY
$18.51 - $24.79 $82,906 - $111,034
4,479 Added 2488.33%
4,659 $111,000
Q2 2022

Jul 25, 2022
BUY
$13.64 - $19.48 $2,455 - $3,506
180 New
180 $3,000

Others Institutions Holding SNDX

# of Institutions
230
Shares Held
90M
Call Options Held
1.01M
Put Options Held
692K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $740M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email